Baxter International Inc.
Market Cap
$9.07B
P/E Ratio
-10.07
EPS
$-1.75
Dividend Yield
2.04%
52-Week Range
$16.84 — $34.55
Volume
5.81M
Avg Volume
9.80M
Beta
0.55
P/E (TTM)
-10.07
Forward P/E
9.15
PEG Ratio
0.05
P/S (TTM)
0.81
P/B (TTM)
1.48
P/FCF
92.89
EV/EBITDA
47.33x
EV/Sales
—
ROE (TTM)
-0.14%
ROA (TTM)
-0.05%
ROIC
-0.00%
Gross Margin
0.30%
Operating Margin
-0.03%
Net Margin
-0.02%
Debt/Equity
1.60
Current Ratio
2.31
EPS Growth (YoY)
-1.33%
Revenue Growth (YoY)
+0.04%
EPS Growth (3Y)
+0.12%
EPS Growth (5Y)
-0.47%
Sales Growth (3Y)
-0.30%
Sales Growth (5Y)
-0.21%
EPS Est (This Year)
$1.93
EPS Est (Next Year)
$2.03
Dividend Yield
—
Annual Dividend
$0.01
Payout Ratio
-1.89%
Frequency
—
Ex-Dividend Date
2025-11-28
Cash/Share
$3.82
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $19.75(12.1% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
514.49M
Float
512.34M
Free Float %
99.58%
RSI (14)
37.52
SMA 20
$20.82
SMA 50
$20.17
SMA 200
$22.94
ATR (14)
1.15
Volatility (Week)
0.02%
Volatility (Month)
0.05%
Pattern
Doji
1 Day
-3.35%
1 Week
-7.76%
1 Month
-5.18%
3 Months
+1.55%
6 Months
-22.92%
1 Year
—
YTD
-2.41%
All-Time High
$37.74
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
NYSE
IPO Date
1981-10-27
Employees
38000
CEO
Andrew Hider
Index Membership
S&P 500
Website
https://www.baxter.com
Baxter International Inc. (BAX) is a healthcare company in the medical - instruments & supplies industry listed on the NYSE. With a market capitalization of $9.07B, a P/E ratio of -10.07, and a dividend yield of 2.04%, BAX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BAX against other stocks using dozens of fundamental and technical filters.
Baxter International Inc. (BAX) has a trailing twelve-month (TTM) P/E ratio of -10.07. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Baxter International Inc. (BAX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Baxter International Inc. (BAX) has a market capitalization of $9.07 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Baxter International Inc. (BAX) with an average score of 2.50 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $19.75 implies 12.1% upside from the current price.
Baxter International Inc. (BAX) has returned -2.41% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.